mainPic
about PharmaEngine

LATEST NEWS

2015/01/21 - Event

PharmaEngine Announces Phase 2 PEPCOL Study Presented at the 2015 ASCO GI of PEP02 (MM-398) in Combination with 5-FU/LV in Unresectable Metastatic Colorectal Cancer

Vision

To be one of the most innovative and successful biopharmaceutical companies specializing for the treatment of cancer and Asian prevalent diseases.

Objectives

PharmaEngine, Inc. is a specialty pharma company which adopts the "no research, development only model" and the "networked pharma model" for new drug development. We license in drug candidates ranging from preclinical to clinical stages and further develop the projects in niche markets.